ETCM
SRPT icon

Evolutionary Tree Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Evolutionary Tree Capital Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,881
Closed -$2.54M – 32
2024
Q4 		$2.54M Sell
20,881
-2,118
-9% -$260K 2.58% 17
2024
Q3 		$2.87M Buy
22,999
+2,036
+10% +$281K 2.88% 16
2024
Q2 		$3.31M Sell
20,963
-5,065
-19% -$651K 3.41% 10
2024
Q1 		$3.37M Buy
26,028
+6,562
+34% +$804K 3.39% 8
2023
Q4 		$1.88M Buy
19,466
+2,816
+17% +$270K 2.07% 23
2023
Q3 		$2.02M Sell
16,650
-3,186
-16% -$360K 2.6% 16
2023
Q2 		$2.27M Sell
19,836
-16,354
-45% -$2.11M 2.73% 13
2023
Q1 		$4.99M Sell
36,190
-27,566
-43% -$3.58M 6.91% 5
2022
Q4 		$8.26M Buy
63,756
+3,525
+6% +$408K 7.93% 1
2022
Q3 		$6.66M Buy
60,231
+10,006
+20% +$1.01M 6.4% 3
2022
Q2 		$3.77M Sell
50,225
-9,074
-15% -$668K 4.1% 9
2022
Q1 		$4.63M Sell
59,299
-37,396
-39% -$2.86M 3.22% 11
2021
Q4 		$8.71M Buy
96,695
+9,482
+11% +$811K 4.18% 7
2021
Q3 		$8.06M Buy
87,213
+8,883
+11% +$684K 3.58% 8
2021
Q2 		$6.09M Buy
78,330
+9,393
+14% +$712K 2.81% 14
2021
Q1 		$5.14M Buy
68,937
+39,265
+132% +$3.62M 3.04% 14
2020
Q4 		$5.06M Buy
+29,672
New +$4.4M 3.86% 9

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Evolutionary Tree Capital Management's SRPT Position: Q1 2025 in Review

Evolutionary Tree Capital Management sold out of Sarepta Therapeutics (SRPT) in Q1 2025, closing a stake of 20,881 shares — an estimated $2.54M sold.

Evolutionary Tree Capital Management first reported a position in SRPT in Q4 2020 and held it in 17 quarters. The position peaked at $8.71M in Q4 2021. 431 funds tracked by Wall St. Rank hold SRPT as of Q1 2025.

  • Evolutionary Tree Capital Management reported no remaining Sarepta Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Evolutionary Tree Capital Management sold 20,881 Sarepta Therapeutics shares in Q1 2025, an estimated $2.54M.
  • Evolutionary Tree Capital Management first reported a position in Sarepta Therapeutics in Q4 2020 and held it in 17 quarters.
  • Evolutionary Tree Capital Management's Sarepta Therapeutics position peaked at $8.71M in Q4 2021.
  • 431 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2025.

Based on Evolutionary Tree Capital Management's 13F filing for Q1 2025, filed 9 May 2025.